No overall change in the rate of weight gain after switching to an integrase-inhibitor in virologically suppressed adults with HIV. [electronic resource]
Producer: 20210125Description: 109-114 p. digitalISSN:- 1473-5571
- Adult
- Aged
- Drug Substitution
- Female
- HIV Infections -- drug therapy
- HIV Integrase Inhibitors -- pharmacology
- HIV-1 -- drug effects
- Heterocyclic Compounds, 3-Ring -- pharmacology
- Humans
- Male
- Middle Aged
- Oxazines -- pharmacology
- Piperazines -- pharmacology
- Pyridones -- pharmacology
- Raltegravir Potassium -- pharmacology
- Retrospective Studies
- Sustained Virologic Response
- Treatment Outcome
- Weight Gain
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.